IL17A exerts its tumor-promoting activity through its type A receptor (IL-17RA), which is expressed in various cell types in the tumor microenvironment, including hematopoietic cells, fibroblasts, and epithelial cells (20). The gene discussed is IL17RA; the disease is neoplasm.